MODELING OF SHORT-ACTING BETA AGONIST (SABA) USE: EFFECT OF SYMPTOM CONTROL IN PATIENTS WITH MODERATE-SEVERE ASTHMA REQUIRING RESCUE MEDICATION

被引：0
|
作者：
Pitrez, Paulo
Brusselle, Guy G.
Yorgancioglu, Arzu
Pavord, Ian D.
Van Dijkman, Sven
Oosterholt, Sean P.
Abhijith, P. G.
Della Pasqua, Oscar
Teli, Chirag
机构：
来源：
CHEST | 2022年 / 162卷 / 04期
关键词：
D O I：
10.1016/j.chest.2022.08.2181
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：2674A / 2676A
页数：3
相关论文
共 50 条
  • [1] Nighttime short-acting beta-agonist (SABA) in asthma and COPD
    Anderson, William
    Gondalia, Rahul
    Hoch, Heather
    Barrett, Meredith
    Szefler, Stanley
    Van Sickle, David
    Stempel, David
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [2] Trends of short-acting beta-agonist (SABA) surrounding days of high use in asthma and COPD
    Hoch, Heather
    Gondalia, Rahul
    Anderson, William
    Barrett, Meredith
    Szefler, Stanley
    Van Sickle, David
    Stempel, David
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [3] DIFFERENCES IN EXACERBATION PATTERNS AND SHORT-ACTING BETA2-AGONIST USE IN PATIENTS WITH MILD VS MODERATE/SEVERE ASTHMA
    Lugogo, N.
    Gilbert, I.
    Gandhi, H.
    Pollack, M.
    Surmont, F.
    Tkacz, J.
    Moore-Schiltz, L.
    Goshi, N.
    Lanz, M.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S32 - S32
  • [4] Short-Acting β-Agonist Use As a Marker of Current Asthma Control
    Patel, Mitesh
    Pilcher, Janine
    Munro, Claire
    Hosking, Alexander
    Pritchard, Alison
    Shaw, Dominick
    Black, Peter
    Weatherall, Mark
    Beasley, Richard
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2013, 1 (04): : 370 - 377
  • [5] The effect of rescue short-acting beta-agonist bronchodilation in patients on Montelukast or Salmeterol
    Storms, WW
    Bird, S
    Firriolo, KM
    Edelman, JM
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (02) : S316 - S316
  • [6] Understanding the effect of clinical baseline characteristics on SABA reliever use in patients with moderate-severe asthma
    Pavord, I.
    Singh, D.
    Garcia, G.
    Van Dijkman, S.
    Oosterholt, S.
    Teli, C.
    Pg, A.
    Della Pasqua, O.
    [J]. ALLERGY, 2023, 78 : 158 - 159
  • [7] Retrospective Analysis on the Use of short-acting Beta-2 Sympathomimetics (SABA) in Patients with Asthma in Germany
    Worth, Heinrich
    Criee, Carl Peter
    Vogelmeier, Claus F.
    Kardos, Peter
    Becker, Eva-Maria
    Kostev, Karel
    Mokros, Ingo
    Schneider, Andrea
    [J]. INTERNIST, 2020, 61 (SUPPL 1): : S61 - S61
  • [8] Impact of a Digital Asthma Intervention on Short-acting Beta-agonist (SABA) Medication Use Among Medicaid-enrolled Children in Southwest Detroit
    Barrett, Meredith
    Gondalia, Rahul
    Rowland, Carolynn
    Hill, Alex
    Attisha, Elliot
    Kaye, Leanne
    Holtrop, Teresa
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB51 - AB51
  • [9] Associations Between Asthma Control, Adherence and Short-Acting Beta2-Agonist (SABA) Use in Patients With Uncontrolled Asthma Using a Maintenance and Reliever Digital System (MRDS)
    Mosnaim, G.
    Hoyte, F.
    Safioti, G.
    Magnus, N.
    Brown, R.
    Hill, T.
    Sagalovich, K.
    Wechsler, M. E.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [10] ASTHMA CONTROL EVALUATED WITH ELECTRONIC MEDICATION MONITOR (EMM)-DEFINED OCCASIONS OF SHORT-ACTING BETA-AGONIST INHALER USE
    Anderson, W.
    Hoch, H.
    Gondalia, R.
    Kaye, L.
    Barrett, M.
    Van Sickle, D.
    Szefler, S.
    Stempel, D.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S40 - S40
12345